Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q2 2024 ▲▼ | Q3 2024 ▲▼ | Change ▲▼ | Q2 2024 ▲▼ | Q3 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Xeris Biopharma Holdings Inc | 5,113,348 | 5,113,348 | 0 | $11.51M | $14.57M | 60.31% | +$3.07M |
| Rezolute, Inc.(RZLT) | 1,318,967 | 1,318,967 | 0 | $5.67M | $6.40M | 26.47% | +$725.4K |
| State Street SPDR S&P 500 ETF TrustTR UNIT(SPY) | 1,869 | 2,867 | +998 | $1.02M | $1.64M | 6.81% | +$628.0K |
| Berkshire Hathaway Inc DelCL B | 1,025 | 1,151 | +126 | $417.1K | $529.6K | 2.19% | +$112.5K |
| Bicara Therapeutics Inc | 0 | 10,941 | +10,941 | $0 | $278.7K | 1.15% | +$278.7K |
| Mind Medicine Mindmed Inc | 30,383 | 34,073 | +3,690 | $219.1K | $193.9K | 0.80% | -$25.2K |
| Lexeo Therapeutics, Inc.(LXEO) | 17,851 | 17,851 | 0 | $286.3K | $161.4K | 0.67% | -$125.0K |
| ABIVAX Société AnonymeADS(ABVX) | 13,900 | 11,365 | -2,535 | $183.8K | $130.9K | 0.54% | -$52.8K |
| Kyverna Therapeutics, Inc.(KYTX) | 22,981 | 22,981 | 0 | $172.4K | $112.4K | 0.47% | -$60.0K |
| Compass Therapeutics, Inc.(CMPX) | 43,465 | 43,465 | 0 | $43.5K | $80.0K | 0.33% | +$36.5K |
| Context Therapeutics Inc.(CNTX) | 18,403 | 18,403 | 0 | $36.9K | $36.1K | 0.15% | -$828 |
| Adicet Bio Inc | 17,488 | 17,488 | 0 | $21.2K | $25.2K | 0.10% | +$4.0K |
| Molecular Templates Inc | 136,866 | 0 | -136,866 | $157.4K | $0 | — | -$157.4K |